Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DON | Ann: Ceasing to be a substantial holder - J.P. Mo | 03/07/13 | 0 | 846 | |||
|
|||||||
DON | Ann: Change in substantial holding - J.P. Morgan | 03/07/13 | 0 | 825 | |||
|
|||||||
DON | Ann: Annual Report to shareholders 2011 | 27/06/13 | 0 | 839 | |||
|
|||||||
DON | Ann: Appendix 3B | 27/06/13 | 0 | 766 | |||
|
|||||||
DON | Ann: Appendix 3B | 27/06/13 | 0 | 733 | |||
|
|||||||
DON | Ann: Appendix 3B | 27/06/13 | 0 | 726 | |||
|
|||||||
DON | Ann: Half Yearly Report and Accounts | 13/05/13 | 0 | 492 | |||
|
|||||||
DON | Ann: Quarterly Activities Report | 30/04/13 | 0 | 630 | |||
|
See All Discussions